Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux - PubMed
Randomized Controlled Trial
. 2006 Sep;101(9):1972-8; quiz 2169.
doi: 10.1111/j.1572-0241.2006.00693.x.
Affiliations
- PMID: 16968502
- DOI: 10.1111/j.1572-0241.2006.00693.x
Randomized Controlled Trial
Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux
John M Wo et al. Am J Gastroenterol. 2006 Sep.
Abstract
Objectives: Results of randomized treatment trials for laryngopharyngeal reflux (LPR) are mixed. The cause and effect between gastroesophageal reflux and laryngeal symptoms remain elusive.
Aims: To determine the efficacy of single-dose pantoprazole in newly diagnosed LPR and to correlate hypopharyngeal reflux with symptom improvement.
Methods: Randomized, double-blind, placebo-controlled trial was performed with a 2-wk run-in, 12-wk treatment period (pantoprazole 40 mg q.a.m. or placebo), and 4-wk follow-up. Study criteria were laryngeal complaints >3 days/wk and a positive triple-sensor pH test. Laryngeal exam was graded using a reflux finding score before and after treatment. Repeat pH test was performed on study drug at week 12. Weekly diaries were kept on symptom severity and global assessment. Total laryngeal symptom score was defined as the sum of six laryngeal symptoms. Mann-Whitney U, Wilcoxon, and Pearson tests were used.
Results: Thirty-nine subjects (13 M/26 F, median age 39 yr) were randomized; 35 completed the study. During the treatment period, total laryngeal symptom scores significantly improved compared with pretreatment scores in both study groups, but there were no significant differences between them. Forty percent of pantoprazole group reported adequate relief at week 12, compared with 42% of placebo group (p= 0.89). No significant improvement in hypopharyngeal reflux was found in either study group. There were no significant correlations between laryngeal reflux finding scores and hypopharyngeal reflux episodes with symptom improvement.
Conclusions: Response was similar between single-dose pantoprazole and placebo in newly diagnosed LPR. Our results suggested that laryngeal exam was not useful in following treatment response. Hypopharyngeal reflux may represent acid reflux or artifacts, but is not likely the underlying cause.
Similar articles
-
Richter JE, Bochenek W. Richter JE, et al. Am J Gastroenterol. 2000 Nov;95(11):3071-80. doi: 10.1111/j.1572-0241.2000.03254.x. Am J Gastroenterol. 2000. PMID: 11095320 Clinical Trial.
-
Armstrong D, Paré P, Pericak D, Pyzyk M; Canadian Pantoprazole GERD Study Group. Armstrong D, et al. Am J Gastroenterol. 2001 Oct;96(10):2849-57. doi: 10.1111/j.1572-0241.2001.4237_a.x. Am J Gastroenterol. 2001. PMID: 11695354 Clinical Trial.
-
van Zyl J, van Rensburg C, Vieweg W, Fischer R. van Zyl J, et al. Digestion. 2004;70(1):61-9. doi: 10.1159/000080130. Epub 2004 Aug 5. Digestion. 2004. PMID: 15297779 Clinical Trial.
-
Gastroesophageal reflux disease and extraesophageal disease.
Katz PO. Katz PO. Rev Gastroenterol Disord. 2005;5 Suppl 2:S31-8. Rev Gastroenterol Disord. 2005. PMID: 16369225 Review.
-
The clinical importance of proton pump inhibitor pharmacokinetics.
Yacyshyn BR, Thomson AB. Yacyshyn BR, et al. Digestion. 2002;66(2):67-78. doi: 10.1159/000065588. Digestion. 2002. PMID: 12428065 Review.
Cited by
-
Kahrilas PJ, Howden CW, Hughes N, Molloy-Bland M. Kahrilas PJ, et al. Chest. 2013 Mar;143(3):605-612. doi: 10.1378/chest.12-1788. Chest. 2013. PMID: 23117307 Free PMC article. Review.
-
Pizzorni N, Ambrogi F, Eplite A, Rama S, Robotti C, Lechien J, Schindler A. Pizzorni N, et al. Eur Arch Otorhinolaryngol. 2022 May;279(5):2533-2542. doi: 10.1007/s00405-021-07219-0. Epub 2022 Jan 15. Eur Arch Otorhinolaryngol. 2022. PMID: 35032204 Free PMC article. Clinical Trial.
-
Floria DE, Obeidat M, Kávási SB, Teutsch B, Veres DS, Hagymási K, Hegyi P, Drug VL, Erőss B. Floria DE, et al. Sci Rep. 2024 May 25;14(1):11956. doi: 10.1038/s41598-024-62640-9. Sci Rep. 2024. PMID: 38796481 Free PMC article.
-
Wei C. Wei C. Eur Arch Otorhinolaryngol. 2016 Nov;273(11):3795-3801. doi: 10.1007/s00405-016-4142-y. Epub 2016 Jun 16. Eur Arch Otorhinolaryngol. 2016. PMID: 27312992 Review.
-
Jeon HK, Kim GH, Cheon YI, Shin SC, Lee BJ. Jeon HK, et al. J Clin Med. 2023 Sep 22;12(19):6116. doi: 10.3390/jcm12196116. J Clin Med. 2023. PMID: 37834761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical